The American College of Obstetricians and Gynecologists (ACOG) recommends acetaminophen (Tylenol) as the preferred first-line analgesic and antipyretic for use during pregnancy when clinically indicated, advising that it should be used at the lowest effective dose for the shortest possible duration. This recommendation is based on extensive epidemiological data showing no clear association between acetaminophen use and major birth defects, miscarriage, or adverse maternal or fetal outcomes when used as directed.
Recent studies have raised concerns about possible associations between prenatal acetaminophen exposure and neurodevelopmental disorders such as ADHD and autism. However, these associations are weak, and confounding factors—such as indication for use, parental health, and genetics—likely explain the observed risks. Large cohort and sibling-control studies have not demonstrated a causal relationship.
ACOG emphasizes that acetaminophen should be reserved for situations where its use is medically necessary, such as for the treatment of fever or significant pain, and that pregnant patients should avoid unnecessary or prolonged use. The maximum recommended adult dose is 4,000 mg per 24 hours and exceeding this increases the risk of hepatotoxicity. Nonpharmacologic options should be considered before medication is initiated.
In summary: ACOG supports the judicious use of acetaminophen in pregnancy, with careful attention to dose and duration, and recommends counseling patients on the evolving evidence and the importance of minimizing unnecessary medication exposure.
Subscribe to our newsletter and receive “The Essential Guide to IVF From Start to Finish” straight to your inbox.
It’s packed with clear, helpful information to support your journey, from how to choose a clinic to understanding the process, and everything in between.
